Myungeun Lee

A Novel Inhibitor IDPP Interferes with Entry and Egress of HCV by Targeting Glycoprotein E1 in a Genotype-Specific Manner

R. Bartenschlager, Ji-Young Lee, Hee-Young Kim, 2017, Scientific reports.

Advanced genetic engineering to achieve in vivo targeting of adenovirus utilizing camelid single domain antibody.

S. Seaman, D. Curiel, I. Dmitriev, 2021, Journal of controlled release : official journal of the Controlled Release Society.

Characterization and structure-activity relationship study of iminodipyridinopyrimidines as novel hepatitis C virus inhibitor.

Hee-Young Kim, Sujin Ahn, M. Windisch, 2017, European journal of medicinal chemistry.

A Novel Piggyback Strategy for mRNA Delivery Exploiting Adenovirus Entry Biology

D. Curiel, L. Aulisa, Ernst Wagner, 2022, Viruses.

Targeting Tumor Neoangiogenesis via Targeted Adenoviral Vector to Achieve Effective Cancer Gene Therapy for Disseminated Neoplastic Disease

D. Curiel, I. Dmitriev, E. Kashentseva, 2020, Molecular Cancer Therapeutics.

Micrococcin P1, a naturally occurring macrocyclic peptide inhibiting hepatitis C virus entry in a pan-genotypic manner.

Hee-Young Kim, Y. Bae, Jaewon Yang, 2016, Antiviral research.

Identification of a resveratrol tetramer as a potent inhibitor of hepatitis C virus helicase

H. Kwon, Hongje Jang, Dal‐Hee Min, 2015, British journal of pharmacology.

Molecular Cancer Therapeutics (Models & Technologies) 1 Targeting tumor neoangiogenesis via targeted adenoviral vector to achieve 2 effective cancer gene therapy for disseminated neoplastic disease

D. Curiel, I. Dmitriev, E. Kashentseva, 2019 .